Managing Partner Joseph Guiliano leads a team of technically sophisticated attorneys and registered patent agents who deliver timely, high-quality patent prosecution services to clients ranging from small start-up companies to large, established domestic and international corporations.
In a practice spanning more than 25 years, Joe has handled intellectual property matters in a wide variety of technical disciplines, including medical devices, cellular telephony, ATM networking, integrated circuits, semiconductor processing, interactive applications for cable and satellite television systems, Internet applications, business methods (including financial systems), retail transaction systems, smart cards, and computer systems and software.
Joe has extensive experience representing clients in connection with patent prosecution, intellectual property transactions, patent infringement and trade secret misappropriation litigation, and opinion matters. He has developed a particular proficiency in counseling clients on intellectual property asset development and management strategies. He advises clients concerning competitive patents, including conducting product clearances and rendering written opinions of noninfringement and invalidity.
Joe’s broad range of experience in intellectual property-related transactions includes negotiating exclusive and nonexclusive licenses, joint development agreements, software development agreements (including website development agreements), and IP asset purchase agreements. He also frequently conducts IP due diligence investigations in connection with mergers, acquisitions, asset purchases, and strategic investments.
Joe’s litigation practice focuses on complex patent and trade secret misappropriation proceedings in federal courts throughout the country. He has developed a focused knowledge in formulating innovative business solutions that lead to favorable settlements of disputes.
Prior to going into practice, Joe was employed by one of the world’s largest pharmaceutical and consumer products companies, where he designed and developed systems to automate laboratory processes and to support preclinical and clinical testing of pharmaceuticals.